Multiple Sclerosis: all 3,524 studies
Page 26 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.
- Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical OutcomesCompletedNCT03066752
- Algorithmic-Based Evaluation and Treatment Approach for Robotic Gait TrainingStatus unknownNCT03057652Not applicable
- Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR ResistanceCompletedNCT03052595
- Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter SettingCompletedNCT03047460
- Effect of Video Game Based Physical Activity Training in Persons With Multiple SclerosisCompletedNCT03045380Not applicable
- Physiotherapist-guided Home Exercise in Moderate to Severe MSCompletedNCT03039400Not applicable
- E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple SclerosisCompletedNCT03029897Not applicable
- pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic StressCompletedNCT03028675
- Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple SclerosisCompletedNCT03025269
- Multiple Sclerosis and PilatesCompletedNCT03006900Not applicable
- Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related SymptomsStatus unknownNCT03005119Phase 2
- Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis CohortCompletedNCT03004794
- Clinical Importance of Glucose Regulation in Relapsing MSStatus unknownNCT03004079
- Multiple Sclerosis Produces Cardiovascular Subclinical DysfunctionStatus unknownNCT03001284
- Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple SclerosisCompletedNCT03000647Not applicable
- Testosterone for Fatigue in Men With MSWithdrawnNCT03000127Phase 2
- Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)Status unknownNCT02992847
- Pilot Diet Study for Multiple SclerosisCompletedNCT02986893Not applicable
- A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCompletedNCT02977533Phase 1
- Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in EgyptCompletedNCT02970370
- Study of Utilization Patterns of Dimethyl Fumarate in GermanyCompletedNCT02969304
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple SclerosisStatus unknownNCT02966808
- Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MSCompletedNCT02965170
- Neurorehabilitation on Upper Limb and on Fatigue in Multiple SclerosisStatus unknownNCT02960984Not applicable
- Dimethyl Fumarate Treatment of Primary Progressive Multiple SclerosisCompletedNCT02959658Phase 2
- Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility StudyCompletedNCT02952911Not applicable
- Plantar Pressure Distribution in Patient With Multiple SclerosisStatus unknownNCT02947906
- Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic ConditionsWithdrawnNCT02939859Phase 1
- National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple SclerosisCompletedNCT02937285Phase 3
- Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)CompletedNCT02921035
- Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue StudyCompletedNCT02914964Not applicable
- Quantitative Fatigue and Muscle Performance in Multiple SclerosisStatus unknownNCT02913209
- Hydroxychloroquine in Primary Progressive Multiple SclerosisCompletedNCT02913157Phase 2
- Optical Coherence Tomography (OCT) Trial in Multiple SclerosisCompletedNCT02907281
- Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple SclerosisTerminatedNCT02904876Phase 4
- Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarateTerminatedNCT02901106Phase 4
- Electrophysiological Study of Spatiotemporal Gait Parameters in Patients in Early Stage of Multiple SclerosisCompletedNCT02896933
- 3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord LesionsTerminatedNCT02896647
- Virtual Reality and Robot Assisted Gait Training in Patients With Multiple SclerosisStatus unknownNCT02896179Not applicable
- Paris Visual Learning Test: a New French Task for Assess Visual Learning and Memory to Multiple Sclerosis PatientsCompletedNCT02893683
- The French Multiple Sclerosis RegistryStatus unknownNCT02889965
- Benefits Evaluation of Selfia® Adapted Underwear for MS Patients Performing Self-catheterizationWithdrawnNCT02889419Not applicable
- French Adaptation of the California Card Sorting Task (CCST) in Multiple SclerosisCompletedNCT02887352
- Evaluation of a Web-Based Fall Prevention Program on People With Multiple SclerosisCompletedNCT02885233Not applicable
- Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise TrainingCompletedNCT02882724Phase 1
- Disability, Perceived Social Support and Quality of Life in Multiple SclerosisCompletedNCT02880553
- Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis PatientsStatus unknownNCT02876536Not applicable
- A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis PatientsTerminatedNCT02874677Not applicable
- How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis?CompletedNCT02870023Not applicable
- To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MSWithdrawnNCT02869425Phase 3
- Correlation Between PET and Advanced MRI in Multiple SclerosisCompletedNCT02869360
- Timing of Acute Palliative Care Consultation in Critically Ill PatientsStatus unknownNCT02858778Not applicable
- Urinary Markers of Detrusor Overactivity in Spina Bifida PatientsCompletedNCT02852317
- GTA-MEG as a Biomarker for Cognition in MSCompletedNCT02851342
- Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.CompletedNCT02849782Phase 4
- Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of LifeCompletedNCT02848976
- The Effects of Focal Vibration on Spasticity in Multiple Sclerosis PatientsStatus unknownNCT02848898Not applicable
- MS Mosaic: A Longitudinal Research Study on Multiple SclerosisCompletedNCT02845635
- Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum DisordersStatus unknownNCT02836327
- Role of Virtual Reality in MS RehabilitationCompletedNCT02834533Not applicable
- Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.TerminatedNCT02833714
- Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing ProcessesCompletedNCT02833142Phase 1
- Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®CompletedNCT02823951
- Enhance Wellness for Individuals With Long-Term Physical DisabilitiesCompletedNCT02815878Not applicable
- MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.CompletedNCT02814487
- Default Mode Network in Multiple SclerosisStatus unknownNCT02810314Not applicable
- Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple SclerosisNo longer availableNCT02807285
- Correlation Between the 'Nine Holes Peg Test' Performance and the Triple Stimulation Technique Within a Group a Patients With Multiple SclerosisCompletedNCT02805634Not applicable
- Fingolimod Real World Experience: the French Grand-Est CohortCompletedNCT02799199
- Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMSCompletedNCT02797015Phase 1
- Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) SyndromeCompletedNCT02790307Phase 2
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis PatientsCompletedNCT02789670
- Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MSCompletedNCT02782858Phase 2
- Motor Imagery Training in Persons With Multiple SclerosisCompletedNCT02781142Not applicable
- Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome MeasuresStatus unknownNCT02777060Not applicable
- Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)CompletedNCT02776072
- Natalizumab Temporary Discontinuation StudyCompletedNCT02775110Phase 4
- Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis PatientsCompletedNCT02771652Not applicable
- Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.Status unknownNCT02769767
- Methylprednisolone During the Switch Between Natalizumab and FingolimodStatus unknownNCT02769689Phase 4
- Telerehabilitation Upper Extremity for Neurological DisordersCompletedNCT02764372Phase 1
- Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen ResearchersStatus unknownNCT02760082
- Pilot Trial of Backwards Walking in Persons With Multiple SclerosisStatus unknownNCT02759211Not applicable
- Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT02753088Phase 3
- Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.CompletedNCT02750982Not applicable
- EPID Multiple Sclerosis Pregnancy StudyCompletedNCT02749396
- Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis PatientsSuspendedNCT02747914Not applicable
- RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.CompletedNCT02746744Phase 3
- Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple SclerosisCompletedNCT02744222Phase 2/3
- Online Program to Reduce Depression in MSCompletedNCT02740361Not applicable
- Depression and Immune Function in Multiple Sclerosis (MS)CompletedNCT02740296
- Effect of Active-Passive Trainer Cycling on Multiple SclerosisCompletedNCT02737904Not applicable
- Impact of Tecfidera on Gut MicrobiotaStatus unknownNCT02736279
- Fatigue and Inspiratory Muscles Training in Patients With Multiple SclerosisTerminatedNCT02726672Not applicable
- Comparison of Intermittent vs. Continuous Walking in MSCompletedNCT02726373Not applicable
- Cognitive and Emotion Regulation Training in MSCompletedNCT02717429Not applicable
- Exercise in Multiple SclerosisTerminatedNCT02716701Not applicable
- Robot-based Rehabilitation of Upper Limb Impairment in Multiple SclerosisCompletedNCT02711566Not applicable
- Emotional Processing, Family Life, Friendship and Social Integration in Patients With Multiple SclerosisCompletedNCT02708927Not applicable